mission_and_strategy_p4.pdf
(551.53 KB, PDF)
… embryo and foetus in order to prevent and treat (hereditary) abnormalities at the (pre-)implantation stage. Furthermore, the programme focusses on the development of the foetus and the mother-child relation to ensure a healthy pregnancy and its outcome. 1.1.2 Strategy and research area The initial strategy was to merge the previously separate programmes (Reproduction and Development and (Epi)genetics of Reproduction and Development), thereby creating more critical mass and stronger interaction between the investigators. Regular programme meetings were mainly organized to discuss each other’s research initiatives and to explore common ground and priorities, while working on the specific recommendations of the 2012 External Review Committee. During that same period the Maastricht UMC+ has identified EVA (Genetics, Reproduction and Development) as a ‘specialty’ within their … Analogous to the future Maastricht Comprehensive Cancer Centre (Maastricht CCC), the aim of programme 4/EVA is to establish a Comprehensive Centre for Reproductive Health (Genetics, Reproduction and Child Health), where the current Programme 4/EVA is responsible for the scientific research. The clinical counterpart is the current Woman, Mother and Child Centre including Clinical Genetics and a multidisciplinary group of paediatricians. For Programme 4 …